Capstone Investment Advisors »

Ascendis Pharma A S shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $464k 3.7k 125.95
2023-09-30 $344k 3.7k 93.64

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Put Option (META)
Amazon Call Option (AMZN)
Apple Put Option (AAPL)
Tesla Motors Put Option (TSLA)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Select Sector Spdr Tr Financial Call Option (XLF)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Broadcom (AVGO)

View all positions for Capstone Investment Advisors

Top funds holding Ascendis Pharma A S

RA Capital Management
Artisan Partners Limited Partnership
Westfield Capital Management Company
Henderson Group
venBio Select Advisor
Wellington Management Company
Massachusetts Financial Services
T. Rowe Price Associates
Franklin Resources
TimesSquare Capital Management
Brown Advisory Holdings Incorporated
Alliancebernstein
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Paradigm Biocapital Advisors

View all funds holding Ascendis Pharma A S